Quinoline derivatives
US7973164B2 · kind B2 · utility
3Cited by
27References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2007 |
| Grant date | Jul 5, 2011 |
| Priority date | — |
| Expiry date | Nov 2, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/233
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns quinoline derivatives of Formula Ior a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.